Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Anxiety disorders; Attention-deficit hyperactivity disorder; Major depressive disorder
- Focus Therapeutic Use
- 01 Aug 2017 Status changed from active, no longer recruiting to completed.
- 01 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Mar 2017.
- 01 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.